UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization

The Journal of pharmacology and experimental therapeutics, 2008-05, Vol.325 (2), p.577

2008

Volltextzugriff (PDF)

Late Hyporegenerative Anemia Following Successful Management of Rh-D Alloimmunization: Still an Underappreciated Entity

Clinical pediatrics, 2021-09, Vol.60 (9-10), p.399-402

2021

Volltextzugriff (PDF)

Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways

The Journal of pharmacology and experimental therapeutics, 2013-06, Vol.345 (3), p.404-418

2013

Volltextzugriff (PDF)

Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells

Molecular cancer therapeutics, 2011-11, Vol.10 (11), p.2124-2134

2011

Volltextzugriff (PDF)

Discovery of the First Potent and Orally Efficacious Agonist of the Orphan G-Protein Coupled Receptor 119

Journal of medicinal chemistry, 2008-09, Vol.51 (17), p.5172-5175

2008

Volltextzugriff (PDF)

Nelotanserin, a novel selective human 5-hydroxytryptamine2A inverse agonist for the treatment of insomnia

The Journal of pharmacology and experimental therapeutics, 2010-01, Vol.332 (1), p.281

2010

Volltextzugriff (PDF)

Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists

The Journal of pharmacology and experimental therapeutics, 2005-05, Vol.313 (2), p.831-839

2005

Volltextzugriff (PDF)

Discovery and SAR of new benzazepines as potent and selective 5-HT2C receptor agonists for the treatment of obesity

Bioorganic & medicinal chemistry letters, 2005-03, Vol.15 (5), p.1467-1470

2005

Volltextzugriff (PDF)

The potential use of selective 5-HT2C agonists in treating obesity

Expert opinion on investigational drugs, 2006-03, Vol.15 (3), p.257-266

2006

Volltextzugriff (PDF)

Novel TRPA1 Antagonists are Multimodal Blockers of Human TRPA1 Channels: Drug Candidates for Treatment of Familial Episodic Pain Syndrome (FEPS)

The FASEB journal, 2020-04, Vol.34 (S1), p.1-1

2020

Volltextzugriff (PDF)

APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biology

The Journal of pharmacology and experimental therapeutics, 2009-10, Vol.331 (1), p.96-103

2009

Volltextzugriff (PDF)

Functional assays for screening GPCR targets

Current opinion in biotechnology, 2005-12, Vol.16 (6), p.655-665

2005

Volltextzugriff (PDF)

A new family of H3 receptor antagonists based on the natural product Conessine

Bioorganic & medicinal chemistry letters, 2008-02, Vol.18 (4), p.1490-1494

2008

Volltextzugriff (PDF)

Variation of Diagnostic Approaches and Treatment Practices for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome Among Pediatric Subspecialists

The Journal of pediatrics, 2023-04, Vol.255, p.65-71.e6

2023

Volltextzugriff (PDF)

A Novel Presentation of Littoral Cell Angioma and Lymphatic Malformations in a Neonate

Pediatrics (Evanston), 2018-04, Vol.141 (Suppl 5), p.S520-S525

2018

Volltextzugriff (PDF)

A Novel Class of Potent, Allosteric TRPA1 Antagonists Reverse Hyperalgesia in Multiple Rat Models of Neuropathic Pain

The FASEB journal, 2016-04, Vol.30 (S1)

2016

Volltextzugriff (PDF)

Regions of PTH(1–34) and PTHrP(1–34) Important for Human PTHR1‐Mediated Signaling

The FASEB journal, 2012-04, Vol.26 (S1)

2012

Volltextzugriff (PDF)

Early Presentation of Homozygous Mismatch Repair Deficient Glioblastoma in Teen With Lynch Syndrome: Implications for Treatment and Surveillance

JCO precision oncology, 2021-11, Vol.5 (5), p.670-675

2021

Volltextzugriff (PDF)

A novel class of allosteric ligands modulating TRPA1: discovery of a switch in agonist‐antagonist function (1061.7)

The FASEB journal, 2014-04, Vol.28 (S1), p.n/a

2014

Volltextzugriff (PDF)

Effects Of Drop Landing Height On Bilateral Asymmetry On Ground Reaction Forces During Depth Jumps

Medicine and science in sports and exercise, 2012-05, Vol.44 (5S), p.863-863

2012

Volltextzugriff (PDF)

Ground Reaction Forces from Depth Jumps at Different Heights do not Support Standard Weight Limitations: 2924 Board #223 June 3 3:30 PM - 5:00 PM

Medicine and science in sports and exercise, 2011-05, Vol.43 (5), p.832

2011

Volltextzugriff (PDF)

Pharmacological characterization of GPR120 ligands

The FASEB journal, 2013-04, Vol.27 (S1)

2013

Volltextzugriff (PDF)

Discovery of 1-[3-(4-Bromo-2-methyl-2 H -pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea (Nelotanserin) and Related 5-Hydroxytryptamine 2A Inverse Agonists for the Treatment of Insomnia

Journal of medicinal chemistry, 2010-03, Vol.53 (5), p.1923-1936

2010

Volltextzugriff (PDF)

Discovery and SAR of new benzazepines as potent and selective 5-HT 2C receptor agonists for the treatment of obesity

Bioorganic & medicinal chemistry letters, 2005-03, Vol.15 (5), p.1467-1470

2005

Volltextzugriff (PDF)

1 – 25 von 308

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(253)
Mit Volltextzugriff
(238)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(306)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(186)
Life Sciences & Biomedicine
(153)
Humans
(89)
Animals
(57)
Male
(54)
Female
(45)
Technology
(35)
Biological And Medical Sciences
(34)
Materials Science
(30)
Physical Sciences
(30)
Cell Biology
(29)
Adult
(26)
Biotechnology
(26)
Engineering
(26)
Middle Aged
(26)
Engineering, Biomedical
(25)
Medical Sciences
(25)
Biochemistry, Biology & Biotechnology
(24)
Biomedical Engineering
(24)
Cell & Tissue Engineering
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization

Late Hyporegenerative Anemia Following Successful Management of Rh-D Alloimmunization: Still an Underappreciated Entity

Parathyroid hormone (PTH) and PTH-related peptide domains contributing to activation of different PTH receptor-mediated signaling pathways

Activation of the insulin-like growth factor-1 receptor induces resistance to epidermal growth factor receptor antagonism in head and neck squamous carcinoma cells

Discovery of the First Potent and Orally Efficacious Agonist of the Orphan G-Protein Coupled Receptor 119

Discovery and Structure−Activity Relationship of (1R)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine (Lorcaserin), a Selective Serotonin 5-HT2C Receptor Agonist for the Treatment of Obesity

Nelotanserin, a novel selective human 5-hydroxytryptamine2A inverse agonist for the treatment of insomnia

Anxiolytic- and antidepressant-like profile of ATC0065 and ATC0175: nonpeptidic and orally active melanin-concentrating hormone receptor 1 antagonists

Discovery and SAR of new benzazepines as potent and selective 5-HT2C receptor agonists for the treatment of obesity

The potential use of selective 5-HT2C agonists in treating obesity

Novel TRPA1 Antagonists are Multimodal Blockers of Human TRPA1 Channels: Drug Candidates for Treatment of Familial Episodic Pain Syndrome (FEPS)

APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biology

Functional assays for screening GPCR targets

A new family of H3 receptor antagonists based on the natural product Conessine

Variation of Diagnostic Approaches and Treatment Practices for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome Among Pediatric Subspecialists

A Novel Presentation of Littoral Cell Angioma and Lymphatic Malformations in a Neonate

A Novel Class of Potent, Allosteric TRPA1 Antagonists Reverse Hyperalgesia in Multiple Rat Models of Neuropathic Pain

Regions of PTH(1–34) and PTHrP(1–34) Important for Human PTHR1‐Mediated Signaling

Early Presentation of Homozygous Mismatch Repair Deficient Glioblastoma in Teen With Lynch Syndrome: Implications for Treatment and Surveillance

A novel class of allosteric ligands modulating TRPA1: discovery of a switch in agonist‐antagonist function (1061.7)

Effects Of Drop Landing Height On Bilateral Asymmetry On Ground Reaction Forces During Depth Jumps

Ground Reaction Forces from Depth Jumps at Different Heights do not Support Standard Weight Limitations: 2924 Board #223 June 3 3:30 PM - 5:00 PM

Pharmacological characterization of GPR120 ligands

Discovery of 1-[3-(4-Bromo-2-methyl-2 H -pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea (Nelotanserin) and Related 5-Hydroxytryptamine 2A Inverse Agonists for the Treatment of Insomnia

Discovery and SAR of new benzazepines as potent and selective 5-HT 2C receptor agonists for the treatment of obesity

Suchergebnisse filtern